Common questions about organoid testing for cancer patients
Quick answers to common questions about organoid testing
Organoid testing grows miniature versions of your tumor in a laboratory and tests many different cancer drugs to see which ones work best against your specific cancer cells.
It's like a "practice run" for your treatment—we find out what works before you receive it.
Genetic (genomic) testing reads your tumor's DNA to find mutations.
Organoid testing actually tests how your tumor responds to drugs.
Example:
We integrate both types of data for the most complete picture.
No. Organoid technology has been validated in thousands of patients across dozens of peer-reviewed studies. It's been shown to predict treatment outcomes with 87-96% accuracy.
While it's newer than genetic testing, it's based on solid science and real clinical outcomes.
Currently, OncoForma focuses on solid tumors, including:
Blood cancers (leukemias, lymphomas) require different approaches and aren't currently offered.
Usually no. We use tissue from biopsies or surgeries you're already having for your diagnosis or treatment.
In rare cases where additional tissue is needed, your doctor will discuss whether another biopsy is appropriate.
The organoid test itself is painless—it happens in a laboratory, not on you.
If tissue collection requires a procedure, any discomfort would be the same as your standard biopsy or surgery. The organoid test adds no extra pain.
4-6 weeks from sample collection to results:
This is fast enough to guide your initial treatment decision.
This happens in 5-15% of cases. If organoids don't grow successfully:
While we don't typically share microscopy images directly with patients, your oncologist receives detailed information about how your organoids grew and responded to treatment.
If you're curious, ask your doctor—we're happy to share educational images!
Your oncologist will receive a report showing:
Highly Sensitive:
Drugs that strongly killed or stopped your tumor cells
Moderately Sensitive:
Drugs with some effectiveness
Resistant:
Drugs unlikely to help
The report also explains how this fits with any genetic testing you've had.
No test can guarantee treatment success, but organoid testing dramatically improves the odds.
Studies show 87-96% correlation between organoid responses and patient outcomes—meaning if your organoids respond well to a drug, you're very likely to as well.
Your oncologist will discuss all options with you, including:
The test doesn't make treatment decisions—it gives you and your doctor better information to make those decisions together.
Organoid testing helps identify the most effective treatment, which can improve outcomes. Studies have shown patients receiving organoid-guided therapy lived longer than those on standard approaches alone.
However, every cancer and every patient is unique. Your oncologist can best discuss your specific prognosis.
Costs vary depending on insurance coverage, typically ranging from $5,000-8,000 for the full screening panel.
We provide cost estimates before testing so there are no surprises.
Coverage is evolving:
Our billing team will work with you to understand your coverage and out-of-pocket costs.
We offer:
Financial concerns should never prevent you from exploring this option. Contact us to discuss your situation.
Consider this: A single round of ineffective chemotherapy can cost $30,000-50,000, plus side effects and disease progression.
Studies show organoid testing saves an average of $47,000 per patient by avoiding ineffective treatments.
The question isn't whether you can afford the test—it's whether you can afford not to have it.
Yes. Samples are:
Samples are either:
You control what happens to your tissue.
Absolutely. We follow HIPAA regulations and maintain strict privacy protections:
Organoid testing is most appropriate for:
Your oncologist will help determine if it's right for you.
That's okay—organoid testing is relatively new to clinical practice, though well-established in research.
We offer:
We can help educate your medical team about how organoid testing might benefit you.
Organoid testing requires a physician order and coordination with your medical team.
Start the conversation with your oncologist. We provide resources to help you discuss whether this test is appropriate for your situation.
Distance isn't a barrier. We work with patients and physicians across North America:
Multiple studies show 87-96% concordance between organoid drug responses and patient clinical outcomes.
This means if your organoids are sensitive to a drug, there's an 87-96% chance you will be too.
Occasionally (5-15% of cases), tumor cells don't grow well in laboratory conditions. This can happen due to:
Success rates are improving as technology advances.
This is an active area of research. Current organoid models are best for:
Immunotherapy prediction is more complex and still being refined.
We're here to help.
📧 Email: patients@oncoforma.com
📞 Phone: [Phone number]
💬 Live Chat: [Available on website]
Or download our comprehensive patient guide:
Download PDF Guide →
No question is too small. Your understanding and comfort matter to us.